Elixinol Wellness Ltd · ASX:EXL

Elixinol Wellness — FY2024 Earnings Presentation

14 slides from Elixinol Wellness's earnings presentation, Feb 28, 2025

  1. Slide 1: FY24 Performance

    akan hee a: Owns FY24 Performance A Sustainable Nutrition Company

  2. Slide 2: Disclaimer

    Disclaimer This presentation has been prepared by Elixinol Wellness Limited (Company). It contains general background information only which is current at the date of this presentation unless otherwise specified. It contains selected summary information and does not purport to be all-inclusive, comp

  3. Slide 3: Elixinol FY24 Performance Overview

    Elixinol FY24 Performance Overview © Wellness ee Ps

  4. Slide 4: FY24 Scorecard

    FY24 Scorecard Strategic Acquisitions Ops. Optimisation Sales Growth • THC and Ananda Food fuelled growth: • Adjusted EBITDA loss improved 40% to • Group revenue reached $15M in FY24, up boosting revenue and advancing the $2.8M (from $4.6M in FY23), driven by 80.9% on FY23, driven by acquisitions an

  5. Slide 5: Financial Highlights

    FY24 Financial Highlights Revenue Growth • Revenue Up 81%: FY24 revenue reached $15.0M ($8.3M in FY23), driven by acquisitions, retail diversification, and an expanded brand portfolio. • Stronger Financial Position: FY24 ended with $1.1M cash and solid short-term funding, extending the financial run

  6. Slide 6: Financial Snapshot (P&L)

    Financial Snapshot (P&L) A$M FY24 FY23 FY22 Profitability Surge Revenue 15.0 8.3 7.1 • NPAT Gains: After-tax loss cut to $1.7M (from $7.5M in FY23), marking a Cost of goods sold (9.3) (4.9) (3.8) significant turnaround. Gross profit 5.6 3.4 3.2 Gross Margin (%) 38% 41% 45% • Board Confidence in Prof

  7. Slide 7: Financial Position

    Financial Position A$M 31-Dec-24 31-Dec-23 Stronger Asset Base Current assets • Total assets up 57% to $18.4M (from $11.7M), driven by the Ananda Cash and cash equivalents 1.1 0.7 Trade & other receivables 1.6 1.7 Foods acquisition and $3.5M intangible asset. Inventories 3.9 3.7 • Inventory stable a

  8. Slide 8: Segment Performance

    Segment Performance Strong Australian Growth • Revenue more than doubled to $12.9M from $5.6M, A$M Australia Americas Corporate FY24 FY23 FY24 FY23 FY24 FY23 driven by organic sales and acquisitions of THC and Revenue 12.9 5.6 2.1 2.6 - - Ananda Foods. Gross profit 4.3 1.7 1.4 1.7 - - • Gross profit

  9. Slide 9: Cash Flow

    FY24 Cash Flow A$M Operating activities FY24 -3.5 FY23 -2.8 Strengthened Position and Path to Profitability Investing activities 0 -1 • $1.1M cash, supported by $3.9M financing inflows, extending Financing activities 3.9 1.6 the financial runway beyond five quarters (ex one-offs). Net increase/(decr

  10. Slide 10: FY25 Growth Strategy

    Elixinol FY25 Growth Strate OWalness au

  11. Slide 11: FY25 Scorecard

    FY25 Scorecard Sustained Expansion Operational Excellence Expand Market Presence Streamline Processes for Greater Efficiency • Scale Healthy Chef and Elixinol USA for • Optimise supply chain and post-merger enhanced profitability synergies • Strengthen hemp dominance in grocery and • Streamline oper

  12. Slide 12: Elixinol House of Brands

    . es EFlixinol House of Brands Wellness Ss oe ae ss —

  13. Slide 13: Brand Highlights

    FY24 Brand Highlights FY24 Sales Performance FY24 Sales Performance FY24 Sales Performance • 46% growth year-on-year • 12%* growth year-on-year • 24% lower year-on-year • Hemp Ingredients • Strong customer loyalty • EBITDA positive, (FY24 $0.1M) • Protein products, • Functional Seed Mixes (Grocery )

  14. Slide 14: Brand Highlights

    FY24 Brand Highlights FY24 Performance FY24 Sales Performance FY24 Sales Performance • Maintained ranging in grocery for • 49%* growth year-on-year • 24%* growth year-on-year hemp ingredients range. • Expanded distribution • Major pet retailers engaged for H2 Growth Strategy • Increased customer loy

Elixinol Wellness — FY2024 Earnings Presentation on 6ix